首页> 外文OA文献 >Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study)
【2h】

Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study)

机译:重症监护病房中危重病人的消化道选择性净化:混合方法可行性研究(SuDDICU研究)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Hospital-acquired infections (HAIs) are a major cause of morbidity and mortality. Critically ill patients in intensive care units (ICUs) are particularly susceptible to these infections. One intervention that has gained much attention in reducing HAIs is selective decontamination of the digestive tract (SDD). SDD involves the application of topical non-absorbable antibiotics to the oropharynx and stomach and a short course of intravenous (i.v.) antibiotics. SDD may reduce infections and improve mortality, but has not been widely adopted in the UK or internationally. Hence, there is a need to identify the reasons for low uptake and whether or not further clinical research is needed before wider implementation would be considered appropriate. Objectives: The project objectives were to (1) identify and describe the SDD intervention, (2) identify views about the evidence base, (3) identify acceptability of further research and (4) identify feasibility of further randomised controlled trials (RCTs).Design : A four-stage approach involving (1) case studies of two ICUs in which SDD is delivered including observations, interviews and documentary analysis, (2) a three-round Delphi study for in-depth investigation of clinicians' views, including semi-structured interviews and two iterations of questionnaires with structured feedback, (3) a nationwide online survey of consultants in intensive care medicine and clinical microbiology and (4) semistructured interviews with international clinical triallists to identify the feasibility of further research.Setting : Case studies were set in two UK ICUs. Other stages of this research were conducted by telephone and online with NHS staff working in ICUs.Participants : (1) Staff involved in SDD adoption or delivery in two UK ICUs, (2) ICU experts (intensive care consultants, clinical microbiologists, hospital pharmacists and ICU clinical leads), (3) all intensive care consultants and clinical microbiologists in the UK with responsibility for patients in ICUs were invited and (4) international triallists, selected from their research profiles in intensive care, clinical trials and/or implementation trials.Interventions : SDD involves the application of topical non-absorbable antibiotics to the oropharynx and stomach and a short course of i.v. antibiotics.Main outcome measures: Levels of support for, or opposition to, SDD in UK ICUs; views about the SDD evidence base and about barriers to implementation; and feasibility of further SDD research (e.g. likely participation rates).Results : (1) The two case studies identified complexity in the interplay of clinical and behavioural components of SDD, involving multiple staff. However, from the perspective of individual staff, delivery of SDD was regarded as simple and straightforward. (2) The Delphi study (n = 42) identified (a) specific barriers to SDD implementation, (b) uncertainty about the evidence base and (c) bimodal distributions for key variables, e.g. support for, or opposition to, SDD. (3) The national survey (n = 468) identified uncertainty about the effect of SDD on antimicrobial resistance, infection rates, mortality and cost-effectiveness. Most participants would participate in further SDD research. (4) The triallist interviews (n = 10) focused largely on the substantial challenges of conducting a large, multinational clinical effectiveness trial.Conclusions : There was considerable uncertainty about possible benefits and harms of SDD. Further large-scale clinical effectiveness trials of SDD in ICUs may be required to address these uncertainties, especially relating to antimicrobial resistance. There was a general willingness to participate in a future effectiveness RCT of SDD. However, support was not unanimous. Future research should address the barriers to acceptance and participation in any trial. There was some, but a low level of, interest in adoption of SDD, or studies to encourage implementation of SDD into practice.
机译:背景:医院获得性感染(HAIs)是发病和死亡的主要原因。重症监护病房(ICU)中的重症患者特别容易受到这些感染的影响。减少HAIs引起广泛关注的一种干预措施是对消化道进行选择性净化。 SDD涉及将局部不可吸收的抗生素应用到口咽和胃中,以及短期静脉注射(i.v.)抗生素。 SDD可以减少感染并提高死亡率,但是在英国或国际上尚未广泛采用。因此,有必要确定摄取率低的原因,以及在认为更广泛的应用之前是否需要进一步的临床研究。目标:该项目的目标是(1)识别和描述SDD干预措施;(2)识别有关证据基础的观点;(3)识别进一步研究的可接受性;(4)识别进一步随机对照试验(RCT)的可行性。设计:四阶段方法,涉及(1)两个SCU的案例研究,其中提供了SDD,包括观察,访谈和文献分析;(2)为期三轮的Delphi研究,用于深入调查临床医生的观点,包括半数结构化的访谈和带有结构化反馈的两次问卷调查;(3)全国重症监护医学和临床微生物学顾问在线调查;(4)与国际临床试验名单的半结构化访谈,以确定进一步研究的可行性。被安置在两个英国ICU中。这项研究的其他阶段是通过电话和在线方式与在ICU中工作的NHS员工进行的。参与者:(1)在两个英国ICU中参与SDD采用或交付的人员,(2)ICU专家(重症监护顾问,临床微生物学家,医院药剂师)和ICU临床负责人),(3)邀请了英国所有负责ICU患者的重症监护顾问和临床微生物学家,以及(4)从他们在重症监护,临床试验和/或实施试验中的研究概况中选择的国际试验名单干预:SDD涉及在口咽部和胃部局部应用不可吸收的抗生素,并在短期内进行静脉注射主要结果指标:英国ICU中SDD的支持或反对水平;关于SDD证据基础和实施障碍的观点;结果:(1)这两个案例研究确定了SDD临床和行为组成部分相互作用的复杂性,涉及多个人员。但是,从个人员工的角度来看,SDD的交付被认为是简单明了的。 (2)Delphi研究(n = 42)确定了(a)实施SDD的具体障碍,(b)证据基础的不确定性和(c)关键变量的双峰分布,例如支持或反对SDD。 (3)全国调查(n = 468)确定了SDD对抗菌素耐药性,感染率,死亡率和成本效益的影响尚不确定。大多数参与者将参加进一步的SDD研究。 (4)试验清单访谈(n = 10)主要集中于进行大型,跨国临床有效性试验的重大挑战。结论:关于SDD的利弊存在相当大的不确定性。为了解决这些不确定性,尤其是与抗药性相关的不确定性,可能需要在ICU中进行SDD的进一步大规模临床有效性试验。人们普遍愿意参加SDD的未来有效性RCT。但是,支持并不一致。未来的研究应解决接受和参与任何试验的障碍。对采用SDD或进行研究以鼓励将SDD付诸实践的研究兴趣不大,但兴趣很低。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号